|
|
| | Aripiprazole N1-Oxide Basic information |
| Product Name: | Aripiprazole N1-Oxide | | Synonyms: | 7-[4-[4-(2,3-Dichlorophenyl)-1-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone;Aripiprazole N1-Oxide;4-(2,3-dichlorophenyl)-1-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl)piperazine 1-oxide;USP Aripiprazole Related Compound F;7-[4-[4-(2,3-Dichlorophenyl)-1-oxidopiperazin-1-yl]butoxy]-3,4-dihydroquinolein-2(1H)-one;Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide);Aripiprazole USP RC F;Aripiprozole-N-Oxide | | CAS: | 573691-09-5 | | MF: | C23H27Cl2N3O3 | | MW: | 464.38 | | EINECS: | | | Product Categories: | Aromatics;Intermediates & Fine Chemicals;Metabolites & Impurities;Neurochemicals;Pharmaceuticals | | Mol File: | 573691-09-5.mol |  |
| | Aripiprazole N1-Oxide Chemical Properties |
| Melting point | >175°C (dec.) | | storage temp. | Hygroscopic, Refrigerator, under inert atmosphere | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 14.41±0.20(Predicted) | | form | solid | | color | White to Off-White | | Stability: | Hygroscopic | | Major Application | pharmaceutical | | InChI | 1S/C23H27Cl2N3O3/c24-19-4-3-5-21(23(19)25)27-10-13-28(30,14-11-27)12-1-2-15-31-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29) | | InChIKey | ZNYNDJDSFMRJPS-UHFFFAOYSA-N | | SMILES | Clc1c(cccc1N2CC[N](=O)(CC2)CCCCOc3cc4c(cc3)CCC(=O)N4)Cl |
| WGK Germany | WGK 1 | | HS Code | 2933790002 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral |
| | Aripiprazole N1-Oxide Usage And Synthesis |
| Uses | A metabolite of anti-psychotic drug, Aripiprazole (A771000). | | Uses | Aripiprazole N1-Oxide (Aripiprazole EP Impurity F) is a metabolite of anti-psychotic drug, Aripiprazole (A771000). |
| | Aripiprazole N1-Oxide Preparation Products And Raw materials |
|